Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
747 | 3107 | 34.4 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
109 | 3 | RECTAL CANCER//COLORECTAL CANCER//COLONOSCOPY | 71522 |
1176 | 2 | THYMIDYLATE SYNTHASE//THYMIDINE PHOSPHORYLASE//5 FLUOROURACIL | 9333 |
747 | 1 | METASTATIC COLORECTAL CANCER//OXALIPLATIN//ADVANCED COLORECTAL CANCER | 3107 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | METASTATIC COLORECTAL CANCER | authKW | 943638 | 8% | 37% | 263 |
2 | OXALIPLATIN | authKW | 870276 | 14% | 20% | 444 |
3 | ADVANCED COLORECTAL CANCER | authKW | 686177 | 4% | 60% | 117 |
4 | IRINOTECAN | authKW | 643223 | 12% | 18% | 360 |
5 | CAPECITABINE | authKW | 482618 | 9% | 18% | 273 |
6 | LEUCOVORIN | authKW | 455047 | 5% | 30% | 157 |
7 | COLORECTAL CANCER | authKW | 332742 | 27% | 4% | 837 |
8 | RALTITREXED | authKW | 287491 | 2% | 43% | 68 |
9 | 5 FLUOROURACIL | authKW | 250738 | 11% | 8% | 334 |
10 | FOLFIRI | authKW | 249042 | 2% | 42% | 60 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 72918 | 78% | 0% | 2415 |
2 | Gastroenterology & Hepatology | 1138 | 7% | 0% | 203 |
3 | Pharmacology & Pharmacy | 988 | 13% | 0% | 397 |
4 | Medicine, General & Internal | 264 | 6% | 0% | 186 |
5 | Surgery | 204 | 7% | 0% | 207 |
6 | Health Care Sciences & Services | 121 | 2% | 0% | 55 |
7 | Geriatrics & Gerontology | 61 | 1% | 0% | 32 |
8 | Health Policy & Services | 42 | 1% | 0% | 27 |
9 | Hematology | 6 | 1% | 0% | 41 |
10 | Infectious Diseases | 2 | 1% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GERCOR | 65500 | 0% | 67% | 10 |
2 | MED ONCOL | 61468 | 17% | 1% | 540 |
3 | SERV MALAD SANGUINES IMMUNITAI TUMORALES | 35090 | 0% | 71% | 5 |
4 | SERV MED INTERNE ONCOL | 30651 | 1% | 20% | 16 |
5 | DIGEST ONCOL UNIT | 28399 | 1% | 12% | 24 |
6 | KENT CANC | 26200 | 0% | 67% | 4 |
7 | MED ONCOL SERV | 25468 | 2% | 3% | 75 |
8 | MED ONCOL UNIT | 23472 | 2% | 4% | 68 |
9 | MODULO ONCOL | 22107 | 0% | 75% | 3 |
10 | CLIN TRIAL PHARMACOL | 19652 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL COLORECTAL CANCER | 200205 | 3% | 21% | 98 |
2 | ANNALS OF ONCOLOGY | 48157 | 6% | 2% | 201 |
3 | JOURNAL OF CLINICAL ONCOLOGY | 22899 | 6% | 1% | 195 |
4 | ONCOLOGY-NEW YORK | 20898 | 2% | 4% | 56 |
5 | ANTI-CANCER DRUGS | 17748 | 2% | 2% | 77 |
6 | ONCOLOGY | 16699 | 3% | 2% | 82 |
7 | SEMINARS IN ONCOLOGY | 14837 | 3% | 2% | 89 |
8 | EUROPEAN JOURNAL OF CANCER | 14773 | 4% | 1% | 123 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 10014 | 3% | 1% | 87 |
10 | ONKOLOGIE | 9405 | 2% | 2% | 50 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METASTATIC COLORECTAL CANCER | 943638 | 8% | 37% | 263 | Search METASTATIC+COLORECTAL+CANCER | Search METASTATIC+COLORECTAL+CANCER |
2 | OXALIPLATIN | 870276 | 14% | 20% | 444 | Search OXALIPLATIN | Search OXALIPLATIN |
3 | ADVANCED COLORECTAL CANCER | 686177 | 4% | 60% | 117 | Search ADVANCED+COLORECTAL+CANCER | Search ADVANCED+COLORECTAL+CANCER |
4 | IRINOTECAN | 643223 | 12% | 18% | 360 | Search IRINOTECAN | Search IRINOTECAN |
5 | CAPECITABINE | 482618 | 9% | 18% | 273 | Search CAPECITABINE | Search CAPECITABINE |
6 | LEUCOVORIN | 455047 | 5% | 30% | 157 | Search LEUCOVORIN | Search LEUCOVORIN |
7 | COLORECTAL CANCER | 332742 | 27% | 4% | 837 | Search COLORECTAL+CANCER | Search COLORECTAL+CANCER |
8 | RALTITREXED | 287491 | 2% | 43% | 68 | Search RALTITREXED | Search RALTITREXED |
9 | 5 FLUOROURACIL | 250738 | 11% | 8% | 334 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
10 | FOLFIRI | 249042 | 2% | 42% | 60 | Search FOLFIRI | Search FOLFIRI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CERSOSIMO, RJ , (2013) MANAGEMENT OF ADVANCED COLORECTAL CANCER, PART 1.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 70. ISSUE 5. P. 395 -406 | 80 | 96% | 11 |
2 | MOTH, EB , VARDY, J , BLINMAN, P , (2016) DECISION-MAKING IN GERIATRIC ONCOLOGY: SYSTEMIC TREATMENT CONSIDERATIONS FOR OLDER ADULTS WITH COLON CANCER.EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. VOL. 10. ISSUE 12. P. 1321 -1340 | 79 | 68% | 0 |
3 | BERRETTA, M , DI BENEDETTO, F , DI FRANCIA, R , LO MENZO, E , PALMERI, S , DE PAOLI, P , TIRELLI, U , (2013) COLORECTAL CANCER IN ELDERLY PATIENTS: FROM BEST SUPPORTIVE CARE TO CURE.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 9. P. 1332-1343 | 71 | 78% | 6 |
4 | GLIMELIUS, B , CAVALLI-BJORKMAN, N , (2012) METASTATIC COLORECTAL CANCER: CURRENT TREATMENT AND FUTURE OPTIONS FOR IMPROVED SURVIVAL MEDICAL APPROACH - PRESENT STATUS.SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. VOL. 47. ISSUE 3. P. 296 -314 | 82 | 63% | 23 |
5 | RAGNHAMMAR, P , HAFSTROM, L , NYGREN, P , GLIMELIUS, B , (2001) A SYSTEMATIC OVERVIEW OF CHEMOTHERAPY EFFECTS IN COLORECTAL CANCER.ACTA ONCOLOGICA. VOL. 40. ISSUE 2-3. P. 282 -308 | 100 | 62% | 135 |
6 | XIONG, HQ , AJANI, JA , (2004) TREATMENT OF COLORECTAL CANCER METASTASIS: THE ROLE OF CHEMOTHERAPY.CANCER AND METASTASIS REVIEWS. VOL. 23. ISSUE 1-2. P. 145 -163 | 88 | 73% | 3 |
7 | WOLPIN, BM , MAYER, RJ , (2008) SYSTEMIC TREATMENT OF COLORECTAL CANCER.GASTROENTEROLOGY. VOL. 134. ISSUE 5. P. 1296 -1310 | 76 | 52% | 209 |
8 | DE GRAMONT, A , FIGER, A , SEYMOUR, M , HOMERIN, M , HMISSI, A , CASSIDY, J , BONI, C , CORTES-FUNES, H , CERVANTES, A , FREYER, G , ET AL (2000) LEUCOVORIN AND FLUOROURACIL WITH OR WITHOUT OXALIPLATIN AS FIRST-LINE TREATMENT IN ADVANCED COLORECTAL CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 18. ISSUE 16. P. 2938 -2947 | 27 | 93% | 2219 |
9 | SIMPSON, D , DUNN, C , CURRAN, M , GOA, KL , (2003) OXIALIPLATIN - A REVIEW OF ITS USE IN COMBINATION THERAPY FOR ADVANCED METASTATIC COLORECTAL CANCER.DRUGS. VOL. 63. ISSUE 19. P. 2127-2156 | 72 | 83% | 34 |
10 | BEKAII-SAAB, T , WU, C , (2014) SEEING THE FOREST THROUGH THE TREES: A SYSTEMATIC REVIEW OF THE SAFETY AND EFFICACY OF COMBINATION CHEMOTHERAPIES USED IN THE TREATMENT OF METASTATIC COLORECTAL CANCER.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 91. ISSUE 1. P. 9-34 | 55 | 73% | 11 |
Classes with closest relation at Level 1 |